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Abstract VASP (vasodilator-stimulated pbospboprotein), a 
protein associated with microfilaments at cellular contact sites, 
has been identified as a ligand for proftin and zyxin, two proteins 
also involved in microfilament dynamics and organization at 
these regions. Here, we report that VASP also directly binds to 
vlnculin, another component of adherens junctions. Competition 
experiments with a vinculin-derived peptide showed that a 
proline-rich motif, located in the hinge region that connects 
vinculin’s head and tail domains, is involved in VASP binding. 
The same motif is present in zyxin but the interactions of VASP 
with vinculln and zyxin differ in detail. Hence, this motif may be 
recognized by VASP in different ways when presented in distinct 
cellular sites. 
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1. Introduction 
VASP, an established substrate of both CAMP- and cGMP- 
dependent protein kinases, is present in high concentrations in 
human platelets and in lower abundance also in a wide variety 
of other mammalian cells and tissues [l]. In tissue culture 
cells, VASP is associated with focal adhesions, microfilaments, 
cell-cell contacts and the leading edge [2-4]. More recently, 
the gene product of the Drosophila gene enabled (ena), which 
has been discovered as a dose-dependent suppressor of abl- 
and disabled (dab)-dependent phenotypes [5], and its mamma- 
lian homologue Mena ([6]; mammalian enabled) have been 
identified as members of the novel Ena-VASP protein family 
which share extended sequence similarity and an overall do- 
main organization originally described for VASP [4-61. Addi- 
tional clues with respect to VASP function came from inves- 
tigations of the actin-based motility of the intracellular 
cytopathogenic bacterium Listeria monocytogenes. Intracellu- 
lar Listeria exploit the host cell actin regulatory system caus- 
ing actin to polymerize at their backpole. This leads to actin 
tail formation and propels the bacteria through the host cell 
cytoplasm eventually forming cell surface protrusions capable 
of infecting neighboring cells [7]. VASP [8], Mena [6], and also 
profilin [9] differ from all the other actin-associated proteins 
tested so far as they are concentrated at one pole of the motile 
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bacteria, i.e. at the base of the actin tail, where actin poly- 
merization is thought to take place. VASP interacts directly 
both with profilin [lo] and with the listerial surface protein 
ActA [S], a protein that is both essential and sufficient for 
intracellular listerial motility and host cell F-actin recruitment, 
respectively [7,11]. More recently, the direct interaction of 
Mena with both profilin and ActA has also been demon- 
strated [6]. Independently, microsequencing [3] and additional 
sequence analysis (M. Reinhard and U. Walter, unpublished 
results) of a VASP binding protein purified from porcine 
platelets using 32P-labeled VASP in blot overlays revealed 
that this VASP binding protein is the porcine equivalent of 
human zyxin (GenBank accession number X94991). The simi- 
lar VASP binding features of ActA and zyxin led to the sug- 
gestion that ActA and zyxin (a possible cellular ActA ana- 
logue) may recruit profilin/profilactin to distinct subcellular 
sites via VASP [3,8] which may be involved in the initiation 
and/or augmentation of spatially confined actin polymeriza- 
tion at these sites [3,8,12]. Whereas profilin interaction with 
VASP involves the poly-L-proline binding site of profilin and 
the GPs repeats containing central proline-rich VASP domain 
[4,10], the Mena N-terminus containing the conserved EVHl 
(Ena-VASP homology 1) domain is sufficient for the interac- 
tion with the proline-rich ligands ActA and zyxin [6]. Deletion 
analysis of mitochondrial targeted ActA transfected into eu- 
karyotic cells revealed that the proline repeats of ActA are 
required for the VASP interaction and efficient actin recruit- 
ment, whereas the proline-rich region and VASP binding are 
not essential for basal actin accumulation [l 11. 
Vinculin is a major component of all types of adherens 
junction [13,14]. It is also an essential protein, as modulation 
of vinculin levels leads to drastic alteration of cellular adhe- 
sion [15]. The tadpole-shaped vinculin has long been known to 
interact with a variety of other focal adhesion proteins, the 
binding sites for which have been mapped either to the glob- 
ular vinculin head, e.g. in the case of talin and a-actinin, or to 
the C-terminal vinculin tail, e.g. for actin and paxillin [15]. 
The vinculin head is capable of folding back to the tail do- 
main [16], thus affecting the interaction with other vinculin 
ligands [17,18] ; this has stimulated intensive research in this 
putative regulatory mechanism of protein-protein interactions. 
The hinge region between the vinculin head and tail domains 
contains a proline-rich region. The similarity of this sequence 
element to the proline motifs of ActA [21] and zyxin 
prompted us to investigate the possibility of a direct VASP- 
vinculin interaction. Here we report that vinculin harbors a 
functional VASP binding site. Our results demonstrate that 
the VASP-vinculin interaction joins the recurring theme of 
VASP interactions with proline-rich ligands, although it dif- 
fers in detail from the binding characteristics reported for the 
couples VASPlzyxin and VASPlActA. 
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2. Materials and methods 
2.1. Protein purification 
Zyxin and VASP were purified from porcine platelets [3]. Vinculin 
was purified from chicken and turkey gizzard, and the MBP-VincS 
fragment was expressed and purified as described [19]. 
2.2. Peptide synthesis 
The human vinculin peptide EPDFPPPPPDLEQLR was synthe- 
sized in N-terminally acetylated and C-terminally amidated form, 
purified (> 95%), and verified by HPLC (VYDAC RP C-S) and 
mass spectrometry (Genosys Biotechnologies, Cambridge, UK). The 
peptide content was estimated to be 60%. The peptide stock solution 
was prepared in PBS and neutralized by the addition of Tris base. 
2.3. Binding assays 
[32P]VASP overlays were performed as described previously [3]. 
Solid phase binding assays were done essentially according to pub- 
lished protocols [lo]. Briefly, for coating native vinculins and MBP- 
Vinci were added directly to removable microtiter wells and diluted to 
final concentrations of 2.5 and 5 &ml, respectively. After blocking 
nonspecific binding sites with 3% (w/v) BSA in PBS, VASP was added 
as a ligand and diluted with BSA solution to a final concentration of 
1.3 &ml. The wells were washed with PBS, and bound VASP was 
detected by incubating the wells with a specific VASP antiserum fol- 
lowed by [‘251]protein A (each in 3% BSA). All incubation volumes 
were 400 ~1, except for the peptide competition and subsequent in- 
cubation steps, which were done in 200 l.d assays. For competition 
experiments, VASP was added to the microtiter wells either without or 
together with the vinculin peptide at a final concentration of 300 PM. 
3. Results 
3.1. VASP binding to vinculin in solid phase binding assays 
To test the possible interaction of VASP and vinculin in 
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Fig. 1. VASP interaction with vinculin in solid phase binding as- 
says. Removable microtiter wells were coated with vinculin (2.5 pg/ 
ml) purified from chicken or turkey gizzard or with the recombinant 
vinculin fragment MBP-Vinc8 (5.0 pg/ml). After blocking nonspecif- 
ic binding sites, VASP was added as a soluble ligand. Bound VASP 
was detected by a specific antiserum followed by [1251]protein A 
(black columns). Wells without coating (hatched column) or without 
addition of VASP (white columns) served as controls. The numbers 
given are means and standard deviations of triplicates of one out of 
several independent experiments. 
vitro, removable microtiter wells were coated with vinculin 
purified from chicken and turkey gizzard. After blocking non- 
specific binding sites with BSA, VASP was added as a soluble 
ligand. Bound VASP was detected with a polyclonal antiser- 
um followed by 1251-labeled protein A. As shown in Fig. 1, 
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Fig. 2. Overview of the binding motifs and domains involved in the VASP-vinculin interaction. A: Alignment of the VASP binding motif of 
human vinculin [25] to the proline-rich repeats of ActA [20,21], chicken zyxin [22], mouse zyxin (GenBank accession number X99063), and hu- 
man zyxin (GenBank accession number X94991). The FPPPP core motif is boxed and acidic residues on both sides are marked in bold. B: 
Mapping of the binding sites of vinculin binding proteins to different vinculin domains (for review, see [l&33]). Numbers given in parentheses 
refer to amino acid positions in the vinculin sequence. The VASP binding motif is located in the putative hinge region between the globular 
head and elongated tail. C: Domain organization of VASP [4,6] and assignment of binding activities for profilin [lo] and - by inference from 
the corresponding Mena data [6] - for ActA, zyxin, and vinculin. Amino acid numbering refers to human VASP [4]. 
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Fig. 3. Comparison of VASP binding to zyxin and vinculin in 
[32P]VASP overlays. Total protein from porcine platelets (20 up), 
zyxin purified from porcine platelets (-80 ng) and vinculin purified 
from chicken gizzard (1 ug) were separated by SDS-PAGE and 
blotted onto nitrocellulose. The membrane was stained with Pon- 
ceau S, blocked and overlaid with [32P]VASP in blocking medium. 
After washing with detergent containing PBS, bound VASP was de- 
tected by autoradiography. The positions of molecular mass stand- 
ards (in kDa) and of vinculin (as determined by Ponceau S staining) 
are marked in the right margin. 
VASP bound significantly and specifically to vinculin-coated 
wells. However, significant VASP binding required vinculin 
concentrations for coating in the range of pglml, which ex- 
ceeds the zyxin concentrations necessary for significant VASP 
binding with an identical assay system [3] by about two orders 
of magnitude. Therefore, it was mandatory to rule out that 
the results obtained might be due to minor zyxin contamina- 
tion present in the vinculin preparations. To this end, two 
different approaches were chosen. First, vinculin was captured 
by coating the microtiter wells with a monoclonal vinculin 
antibody (hVin-1) and tested for VASP binding as described 
above. Again, VASP bound specifically to antibody-captured 
vinculin (not shown), indicating that zyxin contamination was 
not a problem. Second, the solid phase binding assays were 
repeated using a recombinant vinculin fragment (MBP-Vinc8) 
comprising vinculin amino acids 809-1063 fused to maltose 
binding protein [19]. VASP binding to the recombinant pro- 
tein purified from E. coli was similar to that obtained with 
native vinculin (Fig. l), confirming the results obtained with 
vinculin purified from natural sources and ruling out the pos- 
sible contribution of zyxin contamination. At the same time, 
these results indicate that the N-terminal portion of vinculin 
(aa l-808) is not required for the VASP interaction. 
3.2. VASP interaction with vinculin, zyxin, and ActA. 
a common principle 
VASP has been shown to interact in vitro directly with 
ActA [S] and zyxin [3], which both share related proline-rich 
elements [2&22] that are characterized by an FPPPP core 
motif flanked by acidic residues on both sides (Fig. 2A). Since 
VASP recruitment by ActA in intact cells is dependent on the 
presence of these proline-rich repeats [ll], it is reasonable to 
assume that these motifs directly mediate VASP binding. 
Therefore we reasoned that a similar proline-rich motif pres- 
ent in the putative hinge region of vinculin (Fig. 2B) might be 
responsible for the VASP interaction. To test our hypothesis, 
we asked whether the ActA- and zyxin-related vinculin pep- 
tide AC-EPDFPPPPPDLEQLR-NHs would be able to com- 
pete with vinculin for VASP binding in a solid phase binding 
assay. For this purpose, VASP was added either together with 
or in the absence of the peptide to MBP-Vinc%coated micro- 
titer wells. The VASP-vinculin interaction was markedly de- 
creased to 33% residual binding in the presence of the peptide, 
indicating that the proline-rich sequence element in vinculin is 
indeed involved in VASP binding. 
3.3, VASP-vinculin and VASP-zyxin interactions: similar but 
difSerent 
In vitro interactions of VASP with zyxin and ActA have 
been demonstrated not only by solid phase binding assays but 
also in blot overlays with [32P]VASP [3,8]. Interestingly, zyxin 
was the only protein present in total platelet extracts that was 
labeled with [32P]VASP in the overlay assay [3]. In particular, 
there was no protein related in size to vinculin although plate- 
lets are known to contain substantial amounts of vinculin [23]. 
These results are seemingly at variance with the results de- 
scribed above. 
To resolve this issue, we readdressed the problem using 
overlays of purified vinculin and zyxin, which had been sepa- 
rated by SDS-PAGE and blotted onto nitrocellulose. Efficient 
protein transfer was monitored by Ponceau S staining of the 
blot membrane. Although vinculin was present in huge excess 
over zyxin, not even a faint signal could be detected in the 
overlay assay of vinculin, whereas even nanogram amounts of 
zyxin yielded a strongly labeled band. Fig. 3 shows a side-by- 
side comparison of total platelet protein, purified zyxin, and 
vinculin assayed in a [“2P]VASP overlay. These results demon- 
strate that the absence of VASP binding to vinculin in this 
type of assay is not caused by the absence or limited avail- 
other focal adhesion-proteins 
Fig. 4. A model of the concerted action of vinculin and zyxin in 
VASP recruitment and actin polymerization. Binding of VASP to 
zyxin and vinculin is envisaged to have two primary functions: (a) 
consolidation by crosslinking of the meshwork of protein-protein in- 
teractions and providing additional docking points; (b) local in- 
crease of the concentration of polymerization-competent profilactin 
complexes, thus supporting an efficient elongation of actin filaments. 
The depicted addition of profilactin to the barbed ends of actin fila- 
ments is only one example out of several conceivable scenarios (for 
a discussion of additional mechanisms see [12,15]). 
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ability of vinculin on the blot membrane. Instead, the ob- 
served results reflect an inherent difference between the inter- 
actions of VASP with zyxinlActA and vinculin. 
4. Discussion 
In this report we present evidence that a proline-rich motif 
previously identified in zyxin and ActA is a functional VASP 
binding element also in vinculin. In addition, we show that the 
VASP interactions with zyxin and ActA on the one hand and 
vinculin on the other hand differ. These differences are ob- 
vious both in the solid phase binding assays (where vinculin is 
required for coating in markedly higher concentrations than 
zyxin) and in blot overlays (where only zyxin and ActA dis- 
play detectable VASP binding). We would like to suggest that 
these results reflect the fact that vinculin harbors only a single 
FPPPP motif [24,25] whereas both zyxin [22] and ActA [20,21] 
each contain up to four copies of this identified [l l] VASP 
binding motif (Fig. 2A), which might increase the affinity for 
VASP. Such an effect might be enhanced in VASP overlays of 
SDS-denatured vinculin as compared to the native vinculin in 
solid phase binding assays, where oligomerization of vinculin 
may compensate for the single binding site per polypeptide 
chain. Interestingly, affinity chromatography with a fusion 
protein comprising the N-terminal EVHl of the VASP family 
member Mena also resulted in a significantly lower retention 
efficiency for vinculin than for zyxin [6]. Although a direct 
Mena-vinculin interaction has not yet been shown, this obser- 
vation, together with our present results, suggests that the 
vinculin FPPPP motif represents a general binding site for 
the EVHl domain of the VASP family proteins (Fig. 2C). 
Whereas all of the known binding sites for vinculin ligands 
map to either the N-terminal vinculin head or the C-terminal 
vinculin tail (Fig. 2B; for a review see [l&18]), the VASP 
binding element is unique as it is localized at the putative 
hinge region, i.e. at the flexible connection between the vincu- 
lin head and tail domains [24,25]. This might be a crucial 
position to regulate vinculin’s conformation and accessibility 
of ligand binding sites. In the light of recent observations that 
vinculin binding to F-actin [19,26], talin [27], and a-actinin 
[28] is affected by an intramolecular interaction between the 
vinculin head and tail, it will be interesting to investigate 
whether binding of VASP or VASP-related proteins either 
induces or depends on a specific vinculin conformation. 
Vinculin localization at focal adhesions appears to be inde- 
pendent of the interaction with VASP family proteins, as mi- 
croinjection of a proline-rich ActA peptide displaces VASP 
[ll] and Mena [6] but not noticeable amounts of vinculin 
from focal adhesions. Moreover, vinculin fragments lacking 
the VASP binding site are also targeted to focal adhesions 
[29]. Vice versa, VASP localization to stress fibers and the 
leading edge [24] probably does not depend on vinculin, as 
the co-localization of both proteins is mainly restricted to 
focal adhesions and cell-cell contacts [24,13,14]. 
At these sites, vinculin and zyxin may act in concert to 
recruit VASP and related proteins, such as Mena. VASP, 
due to its tetrameric structure [4], may stabilize by cross-link- 
ing homo- or hetero-oligomeric complexes comprising vincu- 
lin and/or zyxin, respectively, and thus initiate the accumula- 
tion of further vinculin and zyxin ligands such as F-actin and 
a-actinin. The profilin binding capacity of VASP and Mena 
[ 10,6] in turn might supply polymerization-competent profilac- 
M. Reinhard et aLlFEES Letters 399 (1996) 103-107 
tin complexes, allowing efficient actin polymerization. These 
events are schematically depicted in Fig. 4. 
Support for a vinculin function as depicted in the model has 
recently come from work on Shigella, which - like Listeria 
spp. - has evolved an actin-based motility system [30]. Unlike 
Listeria however, no direct interaction of VASP with any sur- 
face protein could be detected [8]. Instead, the Shigella VirG/ 
IcsA protein was reported to bind vinculin [31], which in turn 
might serve to recruit VASP or other VASP family proteins. 
The observation that microinjection of a peptide, comprising 
a VASP binding motif of ActA, arrested Shigella actin tail 
formation and intracellular motility [32] despite the lack of 
similar proline-rich sequence stretches in the VirG/IcsA pro- 
tein, is also consistent with such an idea. 
In conclusion, we have shown that vinculin harbors a func- 
tional VASP binding site, which not only joins a recurring 
theme of interactions between VASP family proteins and li- 
gands containing proline-rich sequence motifs, but which also 
has some unique features. Future studies will have to elucidate 
the concerted function of these phosphoproteins in the regula- 
tion of the microfilament system. 
4.1. Note added during revision 
A communication has recently appeared which also demon- 
strates the direct interaction of VASP and vinculin [N.P.J. 
Brindle et al. (1996) Biochem. J. 318, 753-7571. 
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